AzTrials
AzTrials

Kidney StoneNCT05591716

Evaluation of the Efficacy and Safety of Unimodal Bilateral Flexible Ureteroscopy.

A study testing Bilateral same-session flexible ureterorenoscopy and Unilateral same-session flexible ureterorenoscopy in people with Kidney Stone, run by St. Petersburg State Pavlov Medical University at 1 site in Russia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a prospective controlled study to compare the efficacy and safety of two methods of flexible urethroscopy in patients with urolithiasis, as well as the effect of surgery on quality of life. Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Kidney Stone
What is being tested?
Bilateral same-session flexible ureterorenoscopy and Unilateral same-session flexible ureterorenoscopy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
1 siteRussia
Study dates
17 Oct 2022to 17 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Single and bilateral kidney stones with a total 20 mm or less on each side
  • Over 18 years of age
  • Signed informed consent

Who cannot join

  • Patients with large stones (total size greater than 20 mm) and coral stones
  • Urethral and ureteral strictures
  • Urinary tract abnormalities
  • Unwillingness to sign informed consent
  • Presence of active urinary tract infection
  • Pregnant patients

Trial locations and contacts

1 site in 1 country.

Alexander MD Petrov contact

+79302001480

urology@spbpetrov.ru

Ivan MD Gorgotsky, PhD contact

+7 960 269-63-43

igorgotsky@gmail.com

Russia1 site, 1 recruiting
  • Saint-Petersburg State University Hospital

    Saint Petersburg, 190103

    Alexander MD Petrov, +79302001480, urology@spbpetrov.ru

    Ivan Gorgotsky, +7 960 269-63-43, igorgotsky@gmail.com

    Recruiting

Other trials in Russia

About this study

Official title: Evaluation of the Efficacy and Safety of Unimodal Bilateral Flexible Ureteroscopy A Prospective Multicenter Study

This is a prospective controlled study to compare the efficacy and safety of two methods of flexible urethroscopy in patients with urolithiasis, as well as the effect of surgery on quality of life.

Read the detailed description

Retrograde flexible URS is the most modern and safe method of treating patients with bowel stones up to 20 mm. Bilateral kidney stones can be treated with bilateral retrograde flexible URS. This type of surgery allows a patient to get rid of both kidney stones in a single intervention. Technically, the operation can be performed alternately on each side or simultaneously by two surgeons if two flexible instruments and video endoscopic racks are available simultaneously. Flexible ureteroscope diameter of 7.5-9 Сh enables to place two instruments even in the male urethra simultaneously without significant traumatization. One of the disadvantages of this method is the need for bilateral prestenting, with the frequency and the frequency and severity of stent-associated symptoms may increase. Few scientific works demonstrate contradictory data concerning the safety of bilateral flexible URS; therefore, further research is advisable.

All patients meeting the selection criteria will undergo preoperative examination: history, physical, laboratory and CT scan of the kidneys.

MATERIALS AND METHODS To calculate the sample, the investigators used the method for "no lesser efficiency" studies. To confirm the hypothesis of no greater number of complications in the form of upper urinary tract mucosal damage, exit (extravasation) of irrigation solution outside the upper urinary tract, bleeding and perforation of the ureteral wall, which according to the literature are 11.9% for bilateral and 8.5% for unilateral RIRH respectively, a minimum of 82 patients would be required in order to study of 80% and a probability of first-order error of 5% to exclude a 20% difference in the number of complications, which is clinically significant. To compensate for data loss, the sample size is increased by 5% to 86 patients. Categorical variables will be reported as absolute numbers and percentages. Unadapted univariate analyses, to compare the two treatment groups, will be based on Fisher's exact test. Relative risks and 95% confidence intervals will be calculated using the two-by-two table method using a logarithmic approximation. Continuous variables will be displayed as mean ± standard deviation or median and interquartile range.Pre- and postoperative data collected will be anonymized using unique codes that patients will receive immediately after randomization.

All surgical procedures will be performed by 3 qualified surgeons. Postoperative follow-up will be performed 1 day,1 month after surgery by two investigators, a non-blinded study.

Conditions
Kidney Stone
Being tested
Bilateral same-session flexible ureterorenoscopy, Unilateral same-session flexible ureterorenoscopy
Keywords
urolithias, flexible urethroscopy, bilateral flexible urethroscopy, lazer
Medical subject headings
Kidney Calculi

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bilateral same-session flexible ureterorenoscopyProcedure or surgery

    The patient was in the lithotomic position. A semi-rigid ureteroscope was passed into the bladder, then a roadrunner was placed. A flexible urethroscope is guided along the roadrunner to the kidney. In the kidney, the concrement is fragmented with laser energy. The fragments were extracted using a basket. Then a revision of the kidney is performed using a flexible urethroscope. A ureteral stent was placed in the pelvis.The ureteroscope was extracted together with the case with the ureteral revision: there was no damage to the ureter.Next, this procedure is performed from the other side. Urine was excreted from the bladder using a Nelaton catheter.

  • Unilateral same-session flexible ureterorenoscopyProcedure or surgery

    The patient was in the lithotomic position. A semi-rigid ureteroscope was passed into the bladder, then a roadrunner was placed. A flexible urethroscope is guided along the roadrunner to the kidney. In the kidney, the concrement is fragmented with laser energy. The fragments were extracted using a basket. Then a revision of the kidney is performed using a flexible urethroscope. A ureteral stent was placed in the pelvis. The ureteroscope was extracted together with the body with revision of the ureter: there was no damage to the ureter. Urine was excreted from the bladder using a Nelaton catheter.

Study groups in NCT05591716
Study groupRoleWhat they receive
Unilateral flexible ureteroscopyActive comparatorTransurethral removal of kidney stones
Receives: Procedure: Unilateral same-session flexible ureterorenoscopy
Bilateral flexible ureteroscopyActive comparatorTransurethral removal of kidney stones
Receives: Procedure: Bilateral same-session flexible ureterorenoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Objective cure rate

    The frequency of early postoperative complications according to Clavien-Dindo scale starting from the second stage more.

    Measured: 1 day after surgery surgery

Secondary outcomes (5)
  1. Assessment of kidney performance

    Assessment of plasma creatinine level

    Measured: 1 day after surgery surgery

  2. Assessment of the inflammatory process

    body temperature

    Measured: 1 day after surgery surgery

  3. Postoperative examination

    Leukocyte count

    Measured: 1 day after surgery surgery

  4. Evaluation residual stones

    Hydronephrosis and residual stones according to according to ultrasound of kidneys

    Measured: 1 month after surgery surgery

  5. Evaluation stone free rate

    CT scan kidneys

    Measured: 3 month after surgery surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2022
  2. Study start17 Oct 2022
  3. Primary completion17 Feb 2023 (estimated)
  4. Study completion17 May 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
86 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05591716
Sponsor's protocol ID
Uni_or_bilateral
Status last verified
Nov 2022
First submitted
19 Oct 2022
Last updated
16 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Bilateral same-session flexible ureterorenoscopy and Unilateral same-session flexible ureterorenoscopy in people with Kidney Stone, run by St. Petersburg State Pavlov Medical University at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Alexander MD Petrov (+79302001480, urology@spbpetrov.ru), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Objective cure rate (time frame: 1 day after surgery surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in